Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06JUR
|
||||
Former ID |
DNC003668
|
||||
Drug Name |
Rogletimide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Terminated | [544813] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H14N2O2
|
||||
Canonical SMILES |
CCC1(CCC(=O)NC1=O)C2=CC=NC=C2
|
||||
InChI |
1S/C12H14N2O2/c1-2-12(9-4-7-13-8-5-9)6-3-10(15)14-11(12)16/h4-5,7-8H,2-3,6H2,1H3,(H,14,15,16)
|
||||
InChIKey |
QXKJWHWUDVQATH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 121840-95-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [533470] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.